BR0314531A - Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas - Google Patents

Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas

Info

Publication number
BR0314531A
BR0314531A BR0314531-0A BR0314531A BR0314531A BR 0314531 A BR0314531 A BR 0314531A BR 0314531 A BR0314531 A BR 0314531A BR 0314531 A BR0314531 A BR 0314531A
Authority
BR
Brazil
Prior art keywords
nodulisporic acid
acid derivatives
relates
appropriate formulations
parasitic infestations
Prior art date
Application number
BR0314531-0A
Other languages
English (en)
Inventor
Mark D Soll
Albert Boeckh
Ronus De Bode
Peter Johannes Servaas Sa Eijk
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of BR0314531A publication Critical patent/BR0314531A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"FORMULAçõES APROPRIADAS DE DERIVADOS DO áCIDO NODULISPóRICO PARA COMBATER PARASITAS". Esta invenção refere-se, entre outras coisas, a composições de deposição cutânea para o tratamento ou a profilaxia de infestações parasitas em mamíferos ou pássaros que compreende: (1) pelo menos um derivado de ácido nodulispórico; (2) um veículo carreador líquido aceitável; e (3) opcionalmente, um inibidor de cristalização. A invenção também se refere um método de tratamento de infestações parasitas ou para a profilaxia de infestações parasitas em mamíferos ou pássaros que compreende aplicar por via tópica ao referido mamífero ou pássaro uma quantidade eficaz de uma composição de acordo com a presente invenção. Além disso, esta invenção refere-se a um processo de amidação para preparar derivados do tipo amida de ácido nodulispórico e ao intermediário formado neste processo.
BR0314531-0A 2002-10-02 2003-09-29 Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas BR0314531A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41562702P 2002-10-02 2002-10-02
US10/618,975 US20040077703A1 (en) 2002-10-02 2003-07-14 Nodulisporic acid derivative spot-on formulations for combating parasites
PCT/US2003/030500 WO2004030457A1 (en) 2002-10-02 2003-09-29 Nodulisporic acid derivative spot-on formulations for combating parasites

Publications (1)

Publication Number Publication Date
BR0314531A true BR0314531A (pt) 2005-08-09

Family

ID=32073382

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314531-0A BR0314531A (pt) 2002-10-02 2003-09-29 Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas

Country Status (22)

Country Link
US (1) US20040077703A1 (pt)
EP (1) EP1545211B1 (pt)
JP (1) JP2006502241A (pt)
KR (2) KR20050059235A (pt)
CN (1) CN100496244C (pt)
AP (1) AP2047A (pt)
AU (1) AU2003279002A1 (pt)
BR (1) BR0314531A (pt)
CA (1) CA2500822C (pt)
CO (1) CO5700750A2 (pt)
CR (2) CR7810A (pt)
EA (1) EA009683B1 (pt)
EC (1) ECSP055736A (pt)
ES (1) ES2482101T3 (pt)
GE (1) GEP20084414B (pt)
HK (1) HK1072348A1 (pt)
MA (1) MA27457A1 (pt)
MX (1) MXPA05003581A (pt)
NZ (1) NZ539227A (pt)
UA (1) UA83199C2 (pt)
WO (1) WO2004030457A1 (pt)
ZA (1) ZA200502904B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416065B2 (en) * 2007-02-12 2016-08-16 Archer Daniels Midland Company Adjuvants and methods of using them
DK2222168T3 (en) * 2007-11-26 2018-12-03 Merial Inc SOLUTION SYSTEMS FOR POUR-ON FORMULAS TO FIGHT PARASITES
EP2875726A1 (fr) 2013-11-13 2015-05-27 Ceva Animal Health Nouvelles applications de compositions vétérinaires dans le traitement contre les parasites
KR101687973B1 (ko) 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
EP3688174A4 (en) * 2017-09-29 2021-09-08 Victoria Link Limited HETEROLOGICAL BIOSYNTHESIS OF NODULISPORIC ACID
KR102178885B1 (ko) * 2020-01-17 2020-11-13 강현준 카프릴산을 포함하는 안정한 해충 방제제 및 이의 제조방법

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
JPS57139012A (en) * 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (de) * 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
EP0246739B1 (en) * 1986-03-25 1991-01-23 Sankyo Company Limited Macrolide compounds, their preparation and their use
GB8613914D0 (en) * 1986-06-07 1986-07-09 Coopers Animal Health Liquid formulations
ATE75745T1 (de) * 1986-07-02 1992-05-15 Ciba Geigy Ag Pestizide.
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
DE3888936T2 (de) * 1987-11-03 1994-07-21 Beecham Group Plc Zwischenprodukte für die Herstellung makrolider Antibiotika mit anthelmintischer Wirkung.
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
CA2036148A1 (en) * 1990-06-29 1991-12-30 Hiroki Tomioka A 1-phenylimidazole derivative and its production and use
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
DK0611774T3 (da) * 1993-02-19 1999-11-15 Hoffmann La Roche Racemiseringsfri fremstilling af amider og peptider i nærværelse af katalytiske mængder af en N-hydroxyforbindelse
GB9315108D0 (en) * 1993-07-21 1993-09-01 Pfizer Ltd Antiparasitic agents
US5399582A (en) * 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
GB9402916D0 (en) * 1994-02-16 1994-04-06 Pfizer Ltd Antiparasitic agents
JPH0827018A (ja) * 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5595998A (en) * 1994-12-15 1997-01-21 Wolin; Ronald L. Pyrazoloquinolines
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
PL185563B1 (pl) * 1995-03-20 2003-06-30 Merck & Co Inc Pochodne kwasu nodulisporowego oraz zawierające je kompozycje farmaceutyczne
US6221894B1 (en) * 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5595991A (en) * 1995-03-20 1997-01-21 Merck & Co., Inc. Anthelmintic use of nodulisporic acid and analogs thereof
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
US6010710A (en) * 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
US5885607A (en) * 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US5834260A (en) * 1996-08-30 1998-11-10 Merck & Co., Inc. Antiparasitic agents
US6426333B1 (en) * 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
DK0931082T3 (da) * 1996-09-19 2003-04-22 Merck & Co Inc Nodulisporinsyrederivater
FR2753377B1 (fr) * 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6136838A (en) * 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
JP3510591B2 (ja) * 1998-03-30 2004-03-29 エルジ ケミカル リミテッド ポリエトキシル化レチンアミド誘導体およびその製造方法
US6399796B2 (en) * 2000-03-17 2002-06-04 Roche Vitamins Inc. Activation of a Diels-Alder reaction of a sterol 5,7-diene
US6399786B1 (en) * 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US20050234119A1 (en) * 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
US20080003282A1 (en) * 2005-04-18 2008-01-03 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals

Also Published As

Publication number Publication date
CN1700859A (zh) 2005-11-23
ES2482101T3 (es) 2014-08-01
CR10319A (es) 2008-10-21
HK1072348A1 (en) 2005-08-26
CA2500822C (en) 2013-12-24
EA200500579A1 (ru) 2005-08-25
AU2003279002A1 (en) 2004-04-23
CN100496244C (zh) 2009-06-10
CR7810A (es) 2005-05-25
EA009683B1 (ru) 2008-02-28
CO5700750A2 (es) 2006-11-30
CA2500822A1 (en) 2004-04-15
KR20070099668A (ko) 2007-10-09
EP1545211B1 (en) 2014-04-30
NZ539227A (en) 2007-01-26
ECSP055736A (es) 2005-09-20
ZA200502904B (en) 2005-10-19
KR20050059235A (ko) 2005-06-17
WO2004030457A1 (en) 2004-04-15
GEP20084414B (en) 2008-07-10
AP2005003289A0 (en) 2005-06-30
MXPA05003581A (es) 2005-06-17
JP2006502241A (ja) 2006-01-19
US20040077703A1 (en) 2004-04-22
EP1545211A1 (en) 2005-06-29
MA27457A1 (fr) 2005-07-01
AP2047A (en) 2009-09-18
UA83199C2 (ru) 2008-06-25

Similar Documents

Publication Publication Date Title
UY28280A1 (es) 2- hidroxi - 3- diaminoalcanos de benzamida
UY28279A1 (es) Fenacilo 2 -hidroxi - 3 - diaminoalcanos
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
BR0312975A (pt) Forma cristalina de agonista de receptor adrenérgico ß2
BR0113039A (pt) Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto
CR20120007A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
PA8649101A1 (es) Composiciones fungicidas
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
BRPI0410660A (pt) derivados de 2-amino-piridina como agonistas de adrenoreceptor ß2
CL2004000969A1 (es) Compuestos derivados de alquilarilo; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de la obesidad y trastornos relacionados.
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
AU2002342878A1 (en) Pyridylpyrimidine derivatives as effective compounds against prion diseases
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
BR0316629A (pt) Uréias e carbamatos substituìdos
BRPI0506493A (pt) combinações terapêuticas
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
BRPI0411673A (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, e, uso de um composto
BRPI0508927A (pt) compostos úteis para o tratamento de doenças
BR0314531A (pt) Formulações apropriadas de derivados do ácido nodulispórico para combater parasitas
CO2022011258A2 (es) Pirazolo-pirimidinas sustituidas y usos de las mismas
AR117844A1 (es) Derivados de tiazolopiridina como antagonistas del receptor de adenosina
BR0311136A (pt) composto ou um sal, enanciÈmero, diaestereÈmero ou éster hidrolisável in vivo ou mistura dos mesmos farmaceuticamente aceitável, composição, e, método para inibir a atividade de fator letal (lf) liberado de bactérias em um mamìfero
BR9913425A (pt) Derivados de ácido hidroxìmico insaturado comoinibidores parp

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]